# OnCo record nct07284849 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct07284849/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct07284849", "NCT07284849" ;
  schema:name "A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer"@en ;
  schema:description "A phase 3 trial testing INCA33890 in colorectal cancer, now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct07284849/> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT07284849> ;
  onco:status "recruiting" ;
  onco:tag "ctgov-ingest" ;
  onco:phase "3" ;
  schema:startDate "2026-03-05" ;
  onco:cancers <https://onco.cc/cancers/colorectal/> ;
  onco:drugs <https://onco.cc/drugs/inca33890/> ;
  onco:companies <https://onco.cc/companies/incyte/> .
